U.S. mishandling of COVID echoes the 20th century eugenics movement
By Knute Berger,
Crosscut
| 12. 01. 2020
Over the past nine months, I have written about some of the parallels between the 1918-20 influenza pandemic and today’s coronavirus outbreak: opposition to masks, premature elimination of social distancing, increased skepticism about public health, school closures and presidents who made the epidemic a low priority but also caught, and survived, the bug itself.
In the latter case, President Woodrow Wilson, who fell ill in 1919 during treaty talks, was distracted by fighting the first all-out world war. President Donald Trump, on the other hand, became sick after ignoring the advice of his health officials while campaigning for reelection. Trump has long boasted about his health and his smarts. He was hospitalized, given advanced treatments for COVID-19 and, when released, adopted a strongman posture. He and many of his followers believe in their own supremacy — their ability to survive as the fittest of Americans by virtue of their beliefs and their race. White supremacy is, after all, a genetic argument.
Trump has more in common with the prior influenza era: He’s well-known for bragging about his genes. He...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
